Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000424579

Medchemexpress LLC Cyclosomatostatin | 84211-54-1 | 99.8% | 779.97 | 10 MG
SDP

Catalog No. 5000424579
Encompass_Preferred

Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. It can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size, and sphere-formation in colorectal cancer (CRC) cells.

  • Potent somatostatin (SST) receptor antagonist
  • Inhibits somatostatin receptor type 1 (SSTR1) signaling
  • Decreases cell proliferation in colorectal cancer (CRC) cells
  • Decreases ALDH+ cell population size in colorectal cancer (CRC) cells
  • Decreases sphere-formation in colorectal cancer (CRC) cells
  • White to off-white solid appearance
  • Soluble in H2O (5 mg/mL; needs ultrasonic)

Catalog No. 50-004-24579 Supplier Medchemexpress LLC Supplier No. HYP120110MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. It can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size, and sphere-formation in colorectal cancer (CRC) cells.

  • Potent somatostatin (SST) receptor antagonist
  • Inhibits somatostatin receptor type 1 (SSTR1) signaling
  • Decreases cell proliferation in colorectal cancer (CRC) cells
  • Decreases ALDH+ cell population size in colorectal cancer (CRC) cells
  • Decreases sphere-formation in colorectal cancer (CRC) cells
  • White to off-white solid appearance
  • Soluble in H2O (5 mg/mL; needs ultrasonic)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.